CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ·Healthcare·Biotechnology
$3.92
—
Mkt Cap $1.74M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
Implied Upside
-87.2%
Consensus $0.50 vs current $3.92
NASDAQ·Healthcare·Biotechnology
$3.92
—
Mkt Cap $1.74M
No recent rating data.
Price Target (1 analysts)
$0.50
Range $0.50 – $0.50
-87.2%
Consensus $0.50 vs current $3.92